 genetics and embryology of neural tube defects by unknown
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Cerebrospinal Fluid Research
Open AccessInvited speaker presentation
The Casey Holter memorial lecture: genetics and embryology of 
neural tube defects
Andrew Copp
Address: UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
Email: Andrew Copp - A.Copp@ich.ucl.ac.uk
Neurulation is a key event in central nervous system devel-
opment; in which bending and subsequent fusion of the
edges of the neural plate culminate in the formation of the
neural tube, the precursor of the brain and spinal cord.
Failure of neural tube closure results in neural tube defects
(NTDs) in which the lumen of the neural tube remains
open to the amniotic fluid environment. Degeneration of
the neuroepithelium occurs later in gestation leading to
neurological deficit by the time of birth, and severe hand-
icap from the newborn period onwards. While a strong
genetic predisposition to human NTDs is generally
accepted, the genes that mediate this predisposition have
been difficult to identify. In contrast, over 100 genes are
known to be required for mouse neural tube closure, by
virtue of the NTD phenotypes when they are inactivated in
knockout or mutant strains.
The genetic and development events underlying three dif-
ferent types of genetic mouse NTDs can be described as
follows. (1) Failure of the initial step of neurulation (so-
called Closure 1), leads to the most severe NTD, craniora-
chischisis, in which the neural tube remains open from
midbrain to low spine. Recent studies show that initiation
of neurulation requires signalling via the non-canonical
Wnt/dishevelled (planar cell polarity) pathway. (2) Dis-
ruption of dorso-lateral neural plate bending in the low
spinal region, as is seen in the Zic2 mutant mouse, pre-
vents the neural fold tips from coming into apposition,
leading to lumbo-sacral spina bifida. Our recent studies
demonstrate an essential role for signalling via the BMP
and Sonic hedgehog pathways in regulating neural plate
bending. (3) Re-opening of the closed neural tube can
yield a variety of NTDs, including isolated thoracic spina
bifida, not previously seen in mouse genetic models.
Primary prevention of NTDs is now practised clinically
using peri-conceptional folic acid therapy. We have dem-
onstrated that folic acid deficiency is also a risk factor for
NTDs, but only in the presence of a genetic predisposi-
tion, such as seen in the Pax3 (splotch) mutant mouse.
However, a proportion of NTDs in humans and mice do
not respond to folic acid, and we demonstrated that inosi-
tol can be used as an alternative, adjunct therapy where
folic acid is ineffective, such as in the Grhl3 (curly tail)
mouse mutant. A new clinical trial to evaluate inositol as
a preventive agent for NTDs in human pregnancy is now
beginning in the UK http://www.pontistudy.ich.ucl.ac.uk.
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